ARCHIVES

Move Starts To Strip Anticancer Drug Regulation From FDA After New Charges It Is Delaying INDs

This article is from The Cancer Letter archive.

Vol. 02 No. 42 | October 15, 1976

Download PDF Visit The Full Archive

Related Articles

SEC Investigating Bristol-Myers’ Sales Statements

July 12, 2002

NCCS Networker Volume 8 Issue 4, Winter 1994

January 13, 1994

Adjuvant Chemo Improves Survival In Early Lung Cancer

July 30, 2004

Gori to Hopkins Part Time, Keeps DCCP Deputy Job

September 1, 1978

NCI Director John Niederhuber Favors Hands-On Management, Revives Institute’s Former Organizational Structure, Abandons Senior Management Team to Work Closely With Deputies and Division Directors.

September 22, 2006

In Brief: Survey Finds Americans Misinformed About Leading Cause Of Cancer Death

July 10, 1998